Literature DB >> 11176911

Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana.

H C Hendrie1, A Ogunniyi, K S Hall, O Baiyewu, F W Unverzagt, O Gureje, S Gao, R M Evans, A O Ogunseyinde, A O Adeyinka, B Musick, S L Hui.   

Abstract

CONTEXT: Alzheimer disease (AD) represents a major and increasing public health problem. If populations were identified with significantly lower or higher incidence rates of AD, the search for risk factors in the genesis of AD could be greatly enhanced.
OBJECTIVE: To compare incidence rates of dementia and AD in 2 diverse, elderly community-dwelling populations.
DESIGN: The Indianapolis-Ibadan Dementia Project, a longitudinal, prospective population-based study consisting of a baseline survey (1992-1993) and 2 subsequent follow-up waves after 2 years (1994-1995) and 5 years (1997-1998). Each wave followed a 2-stage design, with an in-home screening interview followed by a full diagnostic workup of a subsample of participants based on screening performance. SETTING AND PARTICIPANTS: A total of 2459 community-dwelling Yoruba residents of Ibadan, Nigeria, without dementia, and 2147 community-dwelling African American residents of Indianapolis, Ind, without dementia (all aged 65 years or older). The cohorts were followed up for a mean of 5.1 years and 4.7 years, respectively. MAIN OUTCOME MEASURES: Incident cases of dementia and AD in each of the 2 populations.
RESULTS: The age-standardized annual incidence rates were significantly lower among Yoruba than among African Americans for dementia (Yoruba, 1.35% [95% confidence interval [CI], 1.13%-1.56%]; African Americans, 3.24% [95% CI, 2.11%-4.38%]) and for AD (Yoruba, 1.15% [95% CI, 0.96%-1.35%]; African Americans, 2.52% [95% CI, 1.40%-3.64%]).
CONCLUSION: This is the first report of incidence rate differences for dementia and AD in studies of 2 populations from nonindustrialized and industrialized countries using identical methods and the same group of investigators in both sites. Further explorations of these population differences may identify potentially modifiable environmental or genetic factors to account for site differences in dementia and AD.

Entities:  

Mesh:

Year:  2001        PMID: 11176911     DOI: 10.1001/jama.285.6.739

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  123 in total

1.  Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans.

Authors:  Frederick W Unverzagt; Adesola Ogunniyi; Vanessa Taler; Sujuan Gao; Kathleen A Lane; Olusegun Baiyewu; Oye Gureje; Valerie Smith-Gamble; Ann Hake; Hugh C Hendrie; Kathleen S Hall
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

2.  ACTIVE cognitive training and rates of incident dementia.

Authors:  Frederick W Unverzagt; Lin T Guey; Richard N Jones; Michael Marsiske; Jonathan W King; Virginia G Wadley; Michael Crowe; George W Rebok; Sharon L Tennstedt
Journal:  J Int Neuropsychol Soc       Date:  2012-03-09       Impact factor: 2.892

Review 3.  Normal genetic variation, cognition, and aging.

Authors:  P M Greenwood; Raja Parasuraman
Journal:  Behav Cogn Neurosci Rev       Date:  2003-12

Review 4.  Sirtuins in neurodegenerative diseases: a biological-chemical perspective.

Authors:  Aparna Raghavan; Zahoor A Shah
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

5.  Generalizability: the trees, the forest, and the low-hanging fruit.

Authors:  Walter A Kukull; Mary Ganguli
Journal:  Neurology       Date:  2012-06-05       Impact factor: 9.910

6.  Weight loss and incident dementia in elderly Yoruba Nigerians: a 10-year follow-up study.

Authors:  Adesola Ogunniyi; Su Gao; Frederick W Unverzagt; Olusegun Baiyewu; Oyewusi Gureje; James Tat Nguyen; Valerie Smith-Gamble; Jill R Murrell; Ann M Hake; Kathleen S Hall; Hugh C Hendrie
Journal:  Int Psychogeriatr       Date:  2010-08-25       Impact factor: 3.878

7.  Incidence of dementia and cognitive impairment, not dementia in the United States.

Authors:  Brenda L Plassman; Kenneth M Langa; Ryan J McCammon; Gwenith G Fisher; Guy G Potter; James R Burke; David C Steffens; Norman L Foster; Bruno Giordani; Frederick W Unverzagt; Kathleen A Welsh-Bohmer; Steven G Heeringa; David R Weir; Robert B Wallace
Journal:  Ann Neurol       Date:  2011-03-18       Impact factor: 10.422

8.  Black and white differences in cognitive function test scores: what explains the difference?

Authors:  Kala M Mehta; Eleanor M Simonsick; Ronica Rooks; Anne B Newman; Sandra K Pope; Susan M Rubin; Kristine Yaffe
Journal:  J Am Geriatr Soc       Date:  2004-12       Impact factor: 5.562

9.  Association of statin use with cognitive decline in elderly African Americans.

Authors:  S J Szwast; H C Hendrie; K A Lane; S Gao; S E Taylor; F Unverzagt; J Murrell; M Deeg; A Ogunniyi; M R Farlow; K S Hall
Journal:  Neurology       Date:  2007-11-06       Impact factor: 9.910

Review 10.  Item response theory facilitated cocalibrating cognitive tests and reduced bias in estimated rates of decline.

Authors:  Paul K Crane; Kaavya Narasimhalu; Laura E Gibbons; Dan M Mungas; Sebastien Haneuse; Eric B Larson; Lewis Kuller; Kathleen Hall; Gerald van Belle
Journal:  J Clin Epidemiol       Date:  2008-05-05       Impact factor: 6.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.